Skip to main navigation Skip to search Skip to main content

In vitro effect of Galactose and/or Galactose-1-Phosphate on Insulin-like Growth Factor-1 (IGF-1) receptor and IGF-1 activity in neonate skin fibroblast cultures

Project: RESEARCH PROJECT

Project Details

Description

Classical galactosemia is an inherited metabolic disorder with defective galactose-1-phosphate uridyltransferase (GALT) leading to abnormally high levels of galactose and galactose-1-phosphate in body fluids and tissues. Clinical features of galactosemia are known to vary with gender and race, however galactosemia can be potentially lethal in neonates. Involvement of multiple organs in severe cases of galactosemia causes jaundice, cataract, hypoglycemia, vomiting, hepatomegaly, hypotonia, renal tubular dysfuntion and sepsis. Though various molecular mechanisms have been suggested in relation to pathogenesis of galactosemia, yet any role of Insulin-like growth factor-1 (IGF-1) and its receptor in pathology of galactosemia has remained unexplored. IGF-1 is a potent mitogen with reported proliferative effect on various types of human cells. IGF-1 is a an essential hormone for development of children and plays an important role along with growth hormone at various stages of human growth. In this pilot study, we shall evaluate the effect of supra-physiological levels of galactose on IGF-1 activity and its receptors in cultures of human fibroblasts. These preliminary study should provide new insight into mechanisms of galactosmia-induced cellular events.
StatusFinished
Effective start/end date15/10/16 → 14/02/19

Keywords

  • Galactosemia IGF-1 receptor Galactose-1-phosphate neonates gene expression

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.